PD-1 inhibitor treatment outcomes for cutaneous squamous cell carcinoma in patients over 85: a comparative analysis.

Oncologist · 2026 · PMC13006055 · PMID 41818698

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Survival rates Compared to younger age groups, patients older than 85 showed a trend for worse progression-free survival ( Figure 1 A ), with a median of 15.8 months, compared with 30.6 months for patients younger than 70 and 24.5 months for patients in the 71-84 years group.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.